Smith & Nephew (LON:SN - Get Free Report)'s stock had its "hold" rating reiterated by research analysts at Deutsche Bank Aktiengesellschaft in a research note issued on Tuesday, Digital Look reports. They presently have a GBX 1,250 target price on the stock. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 19.22% from the stock's current price.
A number of other analysts also recently weighed in on SN. Citigroup downgraded shares of Smith & Nephew to a "buy" rating in a research report on Friday, July 10th. JPMorgan Chase & Co. lowered their target price on shares of Smith & Nephew from GBX 1,438 to GBX 1,290 and set a "neutral" rating for the company in a research note on Thursday, August 6th. Royal Bank Of Canada cut their target price on shares of Smith & Nephew from GBX 1,350 to GBX 1,250 and set a "sector perform" rating on the stock in a report on Thursday, August 6th. Jefferies Financial Group reissued a "buy" rating and set a GBX 1,500 price target on shares of Smith & Nephew in a research report on Friday, September 4th. Finally, Shore Capital Group reissued a "buy" rating and issued a GBX 1,000 price target on shares of Smith & Nephew in a report on Tuesday, July 21st. Three research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of GBX 1,293.33.
View Our Latest Research Report on Smith & Nephew
Smith & Nephew Trading Up 4.0%
Shares of LON SN opened at GBX 1,048.50 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 2.14 and a debt-to-equity ratio of 73.07. The company has a market cap of £11.49 billion, a price-to-earnings ratio of 37.75, a PEG ratio of 0.46 and a beta of 0.69. The company has a 50-day simple moving average of GBX 1,106.12 and a 200-day simple moving average of GBX 1,155.57.
Smith & Nephew Company Profile
(
Get Free Report)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.